Donepezil and Vimpat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Donepezil (donepezil hydrochloride) and Vimpat (lacosamide). Common drug interactions include head injury among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Donepezil and Vimpat. It is created by eHealthMe based on reports of 87 people who take the same drugs from the FDA, and is updated regularly.

What is Donepezil?

Donepezil has active ingredients of donepezil hydrochloride. It is often used in dementia. eHealthMe is studying from 24,564 Donepezil users. Check the latest studies of Donepezil.

What is Vimpat?

Vimpat has active ingredients of lacosamide. It is often used in epilepsy. eHealthMe is studying from 20,831 Vimpat users. Check the latest studies of Vimpat.



On Jul, 31, 2026

87 people who take Donepezil and Vimpat together, and have interactions are studied.

Donepezil and Vimpat drug interactions.

What are the common drug interactions of Donepezil and Vimpat, by gender? *:

female:

  1. Head injury
  2. Urinary tract infection
  3. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
  4. Tremor (trembling or shaking movements in one or more parts of your body)
  5. Anger
  6. Bruxism (habitual grinding of the teeth, typically during sleep)
  7. Drug eruption (adverse drug reaction of the skin)
  8. Pneumonia
  9. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  10. Vomiting

male:

  1. Fall
  2. Asthenia (weakness)
  3. Encephalopathy (functioning of the brain is affected by some agent or condition)
  4. Muscular weakness (muscle weakness)
  5. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
  6. Lymphocyte count decreased
  7. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
  8. Platelet count decreased
  9. Activated partial thromboplastin time prolonged
  10. Alanine aminotransferase increased

What are the common drug interactions of Donepezil and Vimpat, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Aggression
  2. Ammonia increased
  3. Balance disorder
  4. Encephalopathy (functioning of the brain is affected by some agent or condition)
  5. Migraine (headache)
  6. Nausea (feeling of having an urge to vomit)
  7. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
  8. Speech disorder
  9. Suicidal ideation
  10. Vomiting

30-39:

  1. Loss of consciousness
  2. Syncope (loss of consciousness with an inability to maintain postural tone)

40-49:

  1. Alanine aminotransferase increased
  2. Anion gap decreased
  3. Balance disorder
  4. Blood albumin decreased
  5. Blood alkaline phosphatase decreased
  6. Blood calcium decreased
  7. Blood creatine decreased
  8. Blood thyroid stimulating hormone increased
  9. Body temperature decreased
  10. Carbon dioxide increased

50-59:

  1. Multiple-drug resistance

60+:

  1. Fall
  2. Dizziness
  3. Loss of consciousness
  4. Tremor (trembling or shaking movements in one or more parts of your body)
  5. Abnormal behaviour
  6. Blood glucose increased
  7. Cerebellar ataxia (loss of coordination)
  8. Cerebellar atrophy (degeneration of the section of the brain responsible for balance, voluntary muscle movements)
  9. Cerebral disorder (brain disease)
  10. Dementia alzheimer's type (loss of mental ability with alzheimer's symptom)

What are the existing conditions these people have? *

  1. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 27 people, 31.03%
  2. Constipation: 15 people, 17.24%
  3. Stress And Anxiety: 13 people, 14.94%
  4. Parkinson's Disease: 13 people, 14.94%
  5. Pain: 13 people, 14.94%
  6. Depression: 12 people, 13.79%
  7. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 10 people, 11.49%
  8. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 9 people, 10.34%
  9. Sleep Disorder: 8 people, 9.20%
  10. Nausea (feeling of having an urge to vomit): 8 people, 9.20%

* Approximation only. Some reports may have incomplete information.

Do you take Donepezil and Vimpat?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Donepezil and Vimpat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Donepezil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vimpat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Donepezil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vimpat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on donepezil hydrochloride and lacosamide (the active ingredients of Donepezil and Vimpat, respectively), and Donepezil and Vimpat (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: